Regeneron’s gene therapy, dubbed DB-OTO, is a cell-selective AAV gene therapy for children with hearing loss stemming from a ...

1-3-6 is that all children, from birth, should be screened for hearing loss by one month of age. And it's because of otoacoustic emissions that we're able to screen newborns in a quick ...

Hearing impairment affects millions globally, with genetics playing a major role in infant hearing loss. Early screening and ...

Hearing Impairment May Be a Sign of Increased Risk of Parkinson's Disease Jan. 14 ... that detect the sound of gunfire to show how often children in one Chicago neighborhood are exposed to ...

SALEM, Ore. (KATU) — Lawmakers are considering a bill that would mandate pre-screenings for cytomegalovirus (CMV) in newborns ...

Aston University's Dr. Amanda Hall and Dr. Helen Pryce have helped to develop a new series of videos to offer guidance and support to parents of very young children diagnosed with mild hearing ...

Regeneron’s gene therapy for otoferlin-related hearing loss – a genetic cause of deafness – has restored hearing to normal levels in one profoundly deaf child within just 24 weeks.

A discussion of the link between hearing loss and cardiovascular disease with Paul Mick, MD, and Anil K Lalwani, MD.

This topic is not my area of expertise. I have many adult patients who began their hearing loss journey as infants, but I do not offer pediatric services. In Pennsylvania, when a child under 18 is ...